We connect patients, experts and pharma for a better life

With the involvement of experts, we enable all pharmaceutical and medical device manufacturers to offer every patient the best digital product or treatment support.

I am curious Check our pitch

The opportunity

Patients demand and need better treatment support

Patients increasingly demand better treatment information, continuous support and want insights from other patients.

If they don't get that, contact Dr. Google and social forums.

70%

want to compare and exchange with other patients, but in a trusted setting.

50%

search for health-related information at least once a week on Google.

40%

have information deficits when it comes to their condition or treatment.

40%

look for alternative treatment options on Google.

The solution

Our ImpactMonitor^TMplatform is here to connect pharma with patients

Our ImpactMonitor^TMplatform is a one-stop-solution connects pharma and experts with their patients to provide them with first-rate digital treatment support.

Expect more informed, loyal, and adherent patients with better treatment outcomes.

I like that

Learn more

Smartphone with the MedWatcher homepage and stories.

One platform, countless possibilities

Smartphone with MedWatcher app that shows an opened story.

Health-related content

Smartphone with Remifemin ImpactMonitor activated.

Proprietary product and therapy areas

Smartphone with ImpactMonitor app and a dropdown with selectable ImpactMonitors.

Easy switching between all areas

The globally unique ImpactMonitor^TM platform

We help you to become more patient-centric

Publish content and become the expert

Provide educational content about conditions and treatments to all patients on MedWatcher^TM and become a trusted expert

Learn more

Provide product or treatment support

Offer digital product or treatment companions easily for your overall product portfolio and reap the benefits of our unique platform.

Learn more

Get access to real-world patient data

Gain insights on high-quality standardised and specific patient reported outcomes on conditions, treatments and products.

Learn more

Digitize your pharmacovigilance

Automatically collect, process and follow up on drug side-effect reports from your patients. Become a health companion they can depend on.

Learn more

The ImpactMonitor^TM-Platform

The unique one-stop shop worldwide for every product and treatment support

There are more than 200,000 medicines and 30,000 diseases in Europe. Do we therefore need a new app for every product and every therapy? Definitely not. Most are already unused today.

That's why we have ImpactMonitor^TM-Platform developed: a one-stop shop that brings together all pharmaceutical and medical device manufacturers to offer all patients digital product or treatment support involving experts.

In addition to the general area - MedWatcher^TM - which we are responsible for together with leading research institutes such as Charité, Every pharmaceutical and medical device manufacturer receives its own product areas. Easily accessible, without effort, from a single application.

I want a demo

Homepage of MedWatcher app in front of a blue background

MedWatcher^TM

To provide general indication-related content and to record standardized patient experiences

ImpactMonitor^TMplatform

Product Spaces

For OTC, RX and MP to digitally support patients using products and therapies on their own

Two smartphones with the MedWatcher app.

Why join the ImpactMonitor^TM platform?

The advantages of the platform compared to a standalone app

We already have everything you need. Save 90% of your costs and time compared to your own development.

Larger reach. Be part of a large offering to patients with higher user returns.

Data-sharing across the platform. Your own app will never have this.

Plenty of synergies between partners you automatically benefit from.

Now I'm in

Our research and industry network

Broad support from top experts

Together, we want to build the largest one-stop Real World patient support platform in Germany. We believe this is the future for the entire industry.